Posts Tagged ‘tax’

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

Union-Jack-flag-with-Brexit-word

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Read More

UK: A GREAT OPTION FOR US R&D

Triangular sign saying explore on a wooden background

WHY THE UK ROCKS FOR RESEARCH During a January visit to San Francisco to coincide with the JP Morgan conference, it was encouraging to hear from one US biotech company CFO how he considered the UK an attractive place to base his company’s research activities – above and beyond any other. Among the reasons why…

Read More

Employment related securities annual returns – what you need to know

Employment related securities

EMPLOYMENT related securities (ERS) are a common way of incentivising employees within the technology and biotechnology industries. However, issuing shares or share options results in a reporting obligation to HMRC, the UK tax authorities. This blog aims to answer the most common queries regarding these annual returns. Overview Any company that has given shares or…

Read More

BUDGET 2017: BEST BITS

Child-using-technology

CONFLUENCE TAX held a post-budget tax briefing for those in the biotech and tech space on November 23, 2017. Here we’ve shared the ‘need to knows’ for all knowledge-intensive companies and investors WHILE MANY commentators on the autumn budget were unmoved, we welcomed various tax changes that affect the knowledge-based businesses we work with –…

Read More

Consulting on HMRC digital improvements project

woman-virtual-reality-HMRC-robot

Confluence Tax has been invited to take part in the HMRC research project into digital improvements to its SEIS, EIS and venture capital trust schemes – a great opportunity for us to have our say on the things that bug both us and our biotech and tech clients about the tax system! This stage of the project…

Read More